Send me a link:

*Text messaging rates may apply.

 Dow Down0.28% Nasdaq Down0.17%

Merrimack Pharmaceuticals, Inc. (MACK)

-NasdaqGM
5.90 0.13(2.16%) Jul 21, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 47,786   48,921   34,215  
Cost of Revenue -   -   -  
Gross Profit 47,786   48,921   34,215  
Operating Expenses
Research Development147,139  125,858  100,630  
Selling General and Administrative21,187  15,805  14,454  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (120,540) (92,742) (80,869)
Income from Continuing Operations
Total Other Income/Expenses Net793  1,541  1,206  
Earnings Before Interest And Taxes(119,747)(91,201)(79,663)
Interest Expense10,938  553  13  
Income Before Tax(130,685)(91,754)(79,676)
Income Tax Expense -   -   -  
Minority Interest(240)477  453  
Net Income From Continuing Ops(130,925)(91,277)(79,223)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (130,925) (91,277) (79,223)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (130,925) (91,277) (79,223)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.